Evidence map›Paper›PMID 42550420›Full record

ArticleDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections2026

Taxonomic Delineation of Fusarium weifangense within the F. incarnatum-equiseti Species Complex.

T Yu Gagkaeva, A S Orina, O P Gavrilova

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

T Yu GagkaevaAll-Russian Institute of Plant Protection, St. Petersburg, Russia. t.gagkaeva@mail.ru.
A S OrinaAll-Russian Institute of Plant Protection, St. Petersburg, Russia.
O P GavrilovaAll-Russian Institute of Plant Protection, St. Petersburg, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern delineation of the Fusarium species using genetic data faces challenges no less complex than those previously encountered, when species descriptions were based exclusively on morphological characteristics. In present study, the taxonomic status of five fungal strains belonging to the F. incarnatum-equiseti species complex, which is a highly heterogeneous group of Fusarium, was clarified. The strains were isolated from wild and cultivated grasses and maintained in the fungal collections for 13-18 years under the epithet F. semitectum (syn. F. incarnatum). More precise identification of these strains as F. weifangense was achieved by combining phylogenetic analysis of fragments of the translation elongation factor 1α gene, the gene encoding RNA polymerase subunit II analyses, and calmodulin gene with morphological description and pathogenicity evaluation. The results of a comparative analysis of the phenotypic characteristics of the strains with those previously reported for this species, which are largely inconsistent. That differences in morphological description may be due to internal polymorphism of taxon, as well as differences in methodological approaches used by different research groups. The analyzed strains caused weak necrosis of wheat leaves inoculated under laboratory conditions, which indicates that F. weifangense is a non-pathogenic fungus. However, the previously demonstrated ability of the F. weifangense strains to produce zearalenone and diacetoxyscirpenol makes it necessary to clarify area and adaptive properties of this fungus.

Indexed as

fungimorphologypathogenicityphylogenetic analysistaxon

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.